NeoStem, Inc.
Autologous CD34+ cell therapy (CLBS14) delivered intracoronary to improve coronary microvascular function
- Sector
- Biotech
- Total capital
- $1.9M
- Federal grants
- $1.9M
- 1 award · 2017
- Rank in peer group#60 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 14 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Exploratory Clinical Study to Evaluate the Potential Bioactivity of CLBS14 in Patients with Coronary Microvascular Dysfunction$1.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#60 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Douglas H.C. LosordoResearcherExecutive OfficerLinked by $1.9M in grants as PI
- Andrew L. PecoraExecutive Officer, DirectorNamed in SEC Form D filings
- Catherine H.C. VaczyExecutive OfficerNamed in SEC Form D filings
- Drew BernsteinDirectorNamed in SEC Form D filings
- Eric H.C. WeiDirectorNamed in SEC Form D filings
- Joseph H.C. TalamoExecutive OfficerNamed in SEC Form D filings
Show all 16 people
- Joseph D ZuckermanDirectorNamed in SEC Form D filings
- Larry A MayExecutive OfficerNamed in SEC Form D filings
- Mark WeinrebExecutive OfficerNamed in SEC Form D filings
- Martyn D. GreenacreDirectorNamed in SEC Form D filings
- Richard J BermanDirectorNamed in SEC Form D filings
- Robert L. Dickey IVExecutive OfficerNamed in SEC Form D filings
- Robert H.C. PretiExecutive OfficerNamed in SEC Form D filings
- Robin L SmithExecutive Officer, DirectorNamed in SEC Form D filings
- Stephen W. PotterExecutive OfficerNamed in SEC Form D filings
- Steven S MyersDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 14- PendingStem Cell Compositions And Methods For Would HealingUSPTOApplication 14773099
- PendingStem Cell Identification And Purification MethodUSPTOApplication 14387467
- PendingCellular Therapeutic Approaches To Traumatic Brain And Spinal Cord InjuryUSPTOApplication 13792368
Show all 14 patent records
- Stem Cell Compositions And Methods For Would HealingJan 14, 2016 · Application 14773099Pending
- Stem Cell Identification And Purification MethodApr 2, 2015 · Application 14387467Pending
- Cellular Therapeutic Approaches To Traumatic Brain And Spinal Cord InjuryFeb 27, 2014 · Application 13792368Pending
- Adult Mesenchymal Stem Cell (msc) Compositions And Methods For Preparing The SameApplication PCTUS2012062837Pending
- Method Of Isolation Of Stem Cell Populations From Peripheral Blood Using Sized-based Separation (elutriation)Application PCTUS2010058974Pending
- Mesenchymal Stem Cells (mscs) Isolated From Mobilized Peripheral BloodApplication PCTUS2010058980Pending
- Method And Composition For Restoration Of Age-related Tissue Loss In The Face Or Selected Areas Of The BodyApplication PCTUS2010033463Pending
- Methods For Isolating Very Small Embryonic-like (vsel) Stem CellsApplication PCTUS2009005414Pending
- Compositions And Methods Using Stem Cells In Cutaneous Wound HealingApplication PCTUS2009038666Pending
- Processing Procedure For Peripheral Blood Stem CellsApplication PCTUS2007014108Pending
- System Capable Of Treating And Defining Various Disease Using Stem CellsApplication PCTUS2004010760Pending
- Elective Collection Banking Of Autologous Peripheral Blood Stem CellsApplication PCTUS2004010500Pending
- Stem Cell Compositions And Methods For Wound HealingApplication PCTUS2014022159Pending
- Stem Cell Identifcation And Purification MethodApplication PCTUS2013033766Pending
Related companies, and why
- ETIRARX, INC.Similar federal contract value in Biotech · null in contracts
- Lila Biologics, Inc.Similar federal contract value in Biotech · null in contracts
- PLEIOGENIX INC.Similar federal contract value in Biotech · null in contracts
- SYMPHONY BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- THERAPYX, INC.Similar federal contract value in Biotech · null in contracts
- Cure Network Dolby Acceleration Partners LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .